Benzamide action at α2-adrenoceptors modifies catecholamine-induced contraction and relaxation of circular smooth muscle from guinea-pig stomach

  • Hassib A. Sahyoun
  • Brenda Costall
  • Robert J. Naylor


Dopamine was shown to act on the circular smooth muscle of the stomach body to cause contraction at a yohimbine-sensitive site (α2) and a relaxation at a prazosin-sensitive site (α1). Metoclopramide and tiapride failed to modify either response, failed to antagonise a relaxation to phenylephrine at 1(α1 sites in the same tissue, and failed to modify the contractions caused by dopamine and phenylephrine at an α2-adrenoceptor site in the pyloric sphincter. However, (+)- and (−)-sultopride and (+)-sulpiride antagonised the dopamine-induced contractions of the stomach body indicating an α2-antagonist action. An ability to attenuate the relaxation of this tissue may reflect a displacement of the contraction curve to the right rather than an α2-antagonist action since the response to phenylephrine was not antagonised either in this tissue or in the pyloric sphincter. Within the central nervous system the (−)-enantiomers of sultopride and sulpiride have a highly selective dopamine receptor blocking action. This cotrasts with the present findings in the stomach musculature of a non-stereospecific antagonism at α2-type adrenoceptors.

Key words

Benzamide derivatives Stomach musculature α1-Adrenoceptors α2-adrenoceptors 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Anderson JD, Day MD, Watson JK (1977) Potentiation by metoclopramide of responses to cholinergic nerve stimulation in the isolated gastric fundus preparation of the rat. J Pharm Pharmacol 29:53PGoogle Scholar
  2. Brodde O-E, Meyer F-J, Schemuth W, Freistuhler J (1981) Demonstration of specific vascular dopamine receptors mediating vasodilation on the isolated rabbit mesenteric artery. Naunyn-Schmiedeberg's Arch Pharmacol 316:24–30Google Scholar
  3. Costall B, Hui S-CG, Naylor RJ (1980) Differential actions of substituted benzamides on pre- and post synaptic dopamine receptor mechanisms in the nucleus accumbens. J Pharm Pharmacol 32:594–596Google Scholar
  4. Costall B, Naylor RJ, Sahyoun HA (1981a) Catecholamines have a dual action on stomach strips: the relaxation component is selectively inhibited by domperidone. Br J Pharmacol 72:558P-559PGoogle Scholar
  5. Costall B, Naylor RJ, Sahyoun HA (1981b) On the nature of the catecholamine receptor mechanisms mediating relaxation and contraction of circular smooth muscle of guinea pig stomach. Br J Pharmacol 74:179P-180PGoogle Scholar
  6. Costall B, Naylor RJ, Sahyoun HA (1981c) Catecholamine-induced relaxation and contraction of the lower oesophageal and pyloric sphincters of guinea pig stomach: modification by domperidone. J Pharm Pharmacol (in press)Google Scholar
  7. Doxey JC, Smith CFE, Walker JM (1977) Selectivity of blocking agents for pre- and postsynaptic α-adrenoceptors. Br J Pharmacol 60:91–96Google Scholar
  8. Drew GM (1977) Pharmacological characterisation of the presynaptic α-adrenoceptor in the rat vas deferens. Eur J Pharmacol 42:123–130Google Scholar
  9. Fosbraey P, Hird MF, Johnson ES (1980) The effects of some dopamine antagonists on cholinergic mechanisms in the guinea-pig ileum. J Auton Pharmacol 1:17–25Google Scholar
  10. Furchgott R (1972) The classification of adrenoceptors (Adrenergic Receptors). An evaluation from the standpoint of receptor theory. Handbook Exp Pharmacol 33:283–335Google Scholar
  11. Illingworth DR, Naylor IL (1980) An inexpensive, electronic digital integrator suitable for use with isolated tissues. J Pharmacol Methods 4:197–207Google Scholar
  12. Jacoby HI, Brodie DA (1967) Gastrointestinal actions of metoclopramide: an experimental study. Gastroenterology 52:676–684Google Scholar
  13. Jenner P, marsden CD (1979) The substituted benzamides — A novel class of dopamine antagonists. Life Sci 25:479–486Google Scholar
  14. Jenner P, Clow A, Reavill C, Theodorou A, Marsden CD (1980) Stereoselective actions of substituted benzamide drugs on cerebral dopamine mechanisms. J Pharm Pharmacol 32:39–44Google Scholar
  15. Pinder RM, Brogden RN, Sawyer Ph R, Speight TM, Avery GS (1976) Metoclopramide: a review of its pharmacological properties and clinical use. Drugs 12:81–131Google Scholar
  16. Spedding M (1980) Effects of metoclopramide and isoprenaline in the rat vas deferens: interactions with α-adrenoceptors. Br J Pharmacol 71:113–120Google Scholar

Copyright information

© Springer-Verlag 1982

Authors and Affiliations

  • Hassib A. Sahyoun
    • 1
  • Brenda Costall
    • 1
  • Robert J. Naylor
    • 1
  1. 1.Postgraduate School of Studies in PharmacologyUniversity of BradfordBradfordUK

Personalised recommendations